Status:
COMPLETED
Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)
Lead Sponsor:
Organon and Co
Conditions:
Hypertension
Eligibility:
All Genders
6-6 years
Phase:
PHASE3
Brief Summary
This study will explore the dose-response of losartan as well as the safety and tolerability in children from 6 months to 6 years of age.
Eligibility Criteria
Inclusion
- Participant is determined to be hypertensive
Exclusion
- Participant has a history of severe or symptomatic hypertension
- Participant has history of heart failure, rhythm disturbance or cardiomyopathy, or obstructive valvular disease
- Participant has started taking hypertensive medications within the past 30 days
- Participant has a known sensitivity to losartan or history of angioneurotic edema
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2012
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00756938
Start Date
March 1 2009
End Date
August 14 2012
Last Update
June 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.